The Epstein-Barr Virus (EBV) market is estimated to be valued at USD 1.4 Billion in 2024 and is expected to reach USD 2.1 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.53% from 2024 to 2031. https://logcla.com/blogs/447393/Epstein-Barr-Virus-EBV-Market-Is-Anticipated-to-Witness-High